Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Daprodustat is an inhibitor of hypoxia-inducible factor prolyl hydroxylase 1 (HIF-PH1), HIF-PH2, and HIF-PH3 (IC50s = 3.5, 22.2, 5.5 nM, respectively).1 It is selective for HIF-PH1, -2, and -3 over factor-inhibiting HIF (FIH) and collagen prolyl hydroxylase (CP4H; IC50s = 9,800 and >200,000 nM, respectively). Daprodustat (25 and 50 µM) induces accumulation of HIF-1α and HIF-2α in Hep3B cells. In vivo, daprodustat (60 mg/kg) increases plasma levels of erythropoietin (EPO) in mice. It increases the number of reticulocytes and levels of hemoglobin in mice when administered at doses of 3, 10, and 30 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery and preclinical characterization of GSK1278863 (daprodustat), a small molecule hypoxia inducible factor-